Table 5.
Preterm infant clinical outcomes
≤ 32 wk STS (N = 10) |
≤ 32 wk non-STS (N = 10) |
> 32 wk STS (N = 12) |
> 32 wk non-STS (N = 10) |
|
---|---|---|---|---|
SNAPPE Acuity Score | 15.2 ± 9.21 | 11.1 ± 5.11 | 4.3 ± 6.67 | 7.9 ± 7.29 |
Antibiotics at birth, N (%) | 9 (90) | 10 (100) | 12 (100) | 10 (100) |
Respiratory intubation at birth, N (%) | 4 (40) | 10 (100)a p < 0.005 |
7 (58) | 6 (60) |
Surfactant at birth, N (%) | 4 (40) | 9 (90) | 7 (58) | 6 (60) |
Age at skin to skin: mean days (range) | 11.1 (1–26) | NA | 10.25 (5–20) | NA |
Length of hospitalization, number of days ± SD | 61 ± 14.8 | 111.8 ± 43.4a | 46.2 ± 18.5 | 65.6 ± 22.4 p < 0.0095 |
Necrotizing enterocolitis with surgery, N (%) | 0 (0) | 2 (20) | 0 (0) | 1 (10) |
Growth velocity, g ± SD | 18.6 ± 4.6 | 15.6 ± 6.8 | 21.6 ± 8.3 | 16.0 ± 3.6 |
After accounting for gestational age and birth weight, length of hospitalization remained significantly different between the STS and non-STS groups.